TechCrunch: M&A

OCTOBER 17, 2024

The all-cash deal is expected to close in Q1 2025, subject to approvals and customary closing conditions. It’ll take Zuora, which is currently publicly traded, private. Tien […] © 2024 TechCrunch. All rights reserved. For personal use only.

Management 319

Management Private Equity Public Trading Equities 319

OfficeHours

OCTOBER 23, 2023

The shares of the company are bought out and delisted from the public stock exchange that the company trades on. First, private equity identifies the publicly traded company they believe is undervalued or could perform better as a private entity without the pressures of being a public entity (e.g.

Investors 130

Investors Private Equity Equities Investment 130

Solganick & Co.

JUNE 2, 2024

It covers the latest M&A transactions, provides a data analytics market map, updates on industry size and growth data, and publicly traded companies and valuations in the sector. June 2, 2024 – Solganick & Co. has published its latest mergers and acquisitions (M&A) and market update and report on the data analytics sector.

M&A 52

M&A Mergers and Acquisitions Mergers Valuation 52

Solganick & Co.

APRIL 24, 2024

Solganick expects M&A deals to increase in the technology services sector for the remainder of 2024 and continuing into 2025. Strategic buyers were more active than financial buyers in 2023 which continued in Q1 2024, with companies including Accenture and Deloitte announcing transactions.

Mergers 52

Mergers Mergers and Acquisitions M&A Consulting 52

Focus Investment Banking

DECEMBER 20, 2024

Cencora, one of the largest publicly-traded pharmaceutical companies in the world, distributes pharmaceuticals, over-the-counter healthcare products and other healthcare supplies and equipment to healthcare providers. The post 2025 Could Be the Year of the Retina Practice Deal appeared first on FOCUS.

Private Equity 52

Private Equity Healthcare Equities Sale 52